Submitting OIG:
Report Description:
The Wyoming Department of Health, Division of Healthcare Financing (State agency), did not always comply with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs. The State agency did not invoice manufacturers for rebates associated with $2.6 million ($1.3 million Federal share) in physician-administered drugs. Of this amount, $2.3 million ($1.2 million Federal share) was for single-source drugs, and $286,000 ($143,000 Federal share) was for top-20 multiple-source drugs. Because the State agency's internal controls did not always ensure that it invoiced manufacturers to secure rebates, the State agency improperly claimed Federal reimbursement for these single-source drugs and top-20 multiple-source drugs.
Date Issued:
Thursday, March 31, 2016
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-07-15-06063
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
WY
United StatesType of Report:
Audit
Questioned Costs:
$1,576,227
Funds for Better Use:
$0
Number of Recommendations:
6
View Document:
Attachment | Size |
---|---|
71506063.pdf | 790.78 KB |
Additional Details Link: